← Back to guidelines
Plastic Surgery3 papers

Intramuscular hemangioma

Last edited:

Overview

Intramuscular hemangiomas are rare vascular malformations characterized by the proliferation of blood vessels within muscle tissue. These lesions are relatively uncommon, accounting for approximately 0.8% of all vascular anomalies [PMID:19659867]. They predominantly affect females, with a female-to-male ratio often observed in reported cases. Clinically, intramuscular hemangiomas can present with a variety of symptoms depending on their size, location, and rate of growth. Common presentations include the development of a palpable mass, pain, and, in some cases, functional impairment related to the affected muscle group. Understanding the epidemiology, clinical presentation, diagnostic approach, and management strategies is crucial for effective patient care and optimal outcomes.

Epidemiology

Intramuscular hemangiomas are considered rare entities within the broader spectrum of vascular malformations, comprising roughly 0.8% of all such cases [PMID:19659867]. The gender distribution of these lesions shows a notable predilection for females, which is consistent across multiple case series. This gender bias suggests potential hormonal influences on their development or presentation. Age-wise, intramuscular hemangiomas can occur at various stages of life, with reported cases ranging from adolescence to adulthood. A specific series highlighted a mean age of 24.6 years (range 15-44 years) among six patients, indicating a tendency towards younger to middle-aged adults [PMID:19659867]. The extremities, particularly the upper and lower limbs, are common sites for these lesions, reflecting the distribution of muscle tissue where they can develop undisturbed. Despite their rarity, recognizing the demographic trends can aid in early suspicion and timely intervention.

Clinical Presentation

The clinical presentation of intramuscular hemangiomas can vary widely based on the lesion's characteristics and location. A notable case described a 43-year-old woman who presented with a gradually enlarging mass and associated pain localized to the right zygomatic bone, highlighting the potential for significant local symptoms [PMID:35760310]. This presentation underscores the importance of considering vascular malformations in the differential diagnosis of facial masses, especially when accompanied by pain. In another series, five women and one man, with a mean age of 24.6 years (range 15-44 years), exhibited lesions predominantly in the extremities—two in the upper limbs and four in the lower limbs [PMID:19659867]. These cases illustrate that intramuscular hemangiomas can cause functional impairment due to their location within muscle groups, leading to symptoms such as pain, swelling, and sometimes limitation of movement. The variability in symptoms emphasizes the need for a thorough clinical evaluation, including detailed patient history and physical examination, to guide further diagnostic workup.

Diagnosis

Diagnosing intramuscular hemangiomas requires a combination of clinical suspicion, imaging studies, and histopathological confirmation. Imaging modalities such as magnetic resonance imaging (MRI) and computed tomography (CT) are invaluable in delineating the extent and nature of the lesion. MRI, in particular, can differentiate between various types of vascular malformations by highlighting the characteristic features of hemangiomas, such as the presence of multiple vascular spaces and the absence of high-signal intensity on T1-weighted images due to the slow flow of blood [PMID:19659867]. Histopathological examination remains definitive, often revealing the hallmark features of cavernous hemangiomas, characterized by large, cavernous spaces lined by a single layer of endothelial cells [PMID:19659867]. In the series cited, microscopic examination confirmed the presence of cavernous hemangiomas in all cases, supporting the utility of biopsy for definitive diagnosis. This multi-modal approach ensures accurate identification and classification of the lesion, crucial for planning appropriate management strategies.

Management

The management of intramuscular hemangiomas typically involves surgical intervention, given the potential for symptomatic relief and prevention of complications such as pain, functional impairment, and aesthetic concerns. A case report detailed a successful surgical approach in a 43-year-old patient with a zygomatic bone hemangioma, where resection was followed by bone reconstruction using a custom-made implant, resulting in no postoperative symptoms and satisfactory aesthetic outcomes [PMID:35760310]. This underscores the feasibility and benefits of tailored surgical techniques in achieving both functional and cosmetic improvements. In another series involving six patients, all underwent surgical resection, with follow-up periods ranging from 1 to 3 years showing no recurrence and good functional and aesthetic outcomes [PMID:19659867]. These outcomes highlight the efficacy of surgical excision as a primary treatment modality. However, the decision to proceed with surgery should consider the lesion's size, location, and the patient's overall health status, alongside a thorough discussion of potential risks and benefits.

Prognosis & Follow-up

The prognosis for patients with intramuscular hemangiomas who undergo surgical management is generally favorable, with long-term outcomes often reflecting the success of the intervention. Postoperative follow-up in the case of the 43-year-old patient demonstrated sustained symptom resolution and maintained symmetry, indicating a positive long-term prognosis [PMID:35760310]. Similarly, the series of six patients showed no recurrence at 1-3 years post-surgery, with patients experiencing good functional recovery and aesthetic satisfaction [PMID:19659867]. Regular follow-up is essential to monitor for any signs of recurrence or complications, although these are rare with complete surgical excision. Clinicians should emphasize the importance of periodic clinical assessments and imaging studies as needed to ensure sustained remission and address any emerging issues promptly. This proactive approach supports maintaining the positive outcomes observed in treated cases.

Key Recommendations

  • Clinical Suspicion: Maintain a high index of suspicion for intramuscular hemangiomas, particularly in females and younger to middle-aged adults presenting with a palpable mass and pain, especially in the extremities.
  • Diagnostic Workup: Utilize MRI and CT imaging to characterize the lesion, followed by histopathological examination for definitive diagnosis.
  • Surgical Management: Consider surgical resection as the primary treatment modality, especially for symptomatic lesions. Tailor surgical techniques to address both functional and aesthetic concerns.
  • Follow-Up Care: Implement a structured follow-up plan post-surgery, including clinical evaluations and imaging studies, to monitor for recurrence and ensure long-term patient satisfaction and functional outcomes.
  • Patient Counseling: Engage in comprehensive patient counseling regarding the nature of the condition, treatment options, potential risks, and expected outcomes to facilitate informed decision-making.
  • References

    1 Laurian LJ, Decaudaveine S, Caillot A, Walter P, Benichou L. Case report of a zygomatic bone hemangioma surgery with reconstruction by a custom-made implant. Journal of stomatology, oral and maxillofacial surgery 2022. link 2 Ranero-Juárez AG, Rosales-Galindo VM, León-Takahashi AM, Arenas-Guzmán R, García C. Intramuscular hemangiomas of the extremities: report of six cases. International journal of dermatology 2009. link

    2 papers cited of 3 indexed.

    Original source

    1. [1]
      Case report of a zygomatic bone hemangioma surgery with reconstruction by a custom-made implant.Laurian LJ, Decaudaveine S, Caillot A, Walter P, Benichou L Journal of stomatology, oral and maxillofacial surgery (2022)
    2. [2]
      Intramuscular hemangiomas of the extremities: report of six cases.Ranero-Juárez AG, Rosales-Galindo VM, León-Takahashi AM, Arenas-Guzmán R, García C International journal of dermatology (2009)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG